Biomarkers Accurately Inform Treatment Decisions in Localized Prostate Cancer.
Journal Article (Journal Article)
Biomarkers are now ubiquitous in prostate cancer care. In addition to longstanding use of prostate-specific antigen, we now have secondary serum-, urine-, and tissue-based markers that help in optimizing patient care and patient compliance with therapeutic recommendations. The ship has sailed: these markers are useful and are here to stay.
- Moul, JW
- May 2022
Volume / Issue
- 8 / 3
Start / End Page
- 641 - 642
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)